STAT compiled a list of seven key quandaries that scientists, drugmakers and government officials have struggled to conclusively address. They are:
- Vaccination of special populations with little or no data on how the vaccine affects them.
- Definition of high-risk healthcare workers and essential workers.
- Process for those who need to prove they have a high-risk medical condition to gain earlier vaccine access.
- Ability to transport vaccines rapidly with slowed air travel.
- Wide use of Pfizer and BioNTech’s vaccine, which must be stored at -94 degrees.
- Pfizer and BioNTech’s ordering system, which stipulates 975 doses as the lowest possible order.
- Ability to keep vaccines safe from theft and counterfeits.
More articles on pharmacy:
Health officials scramble to get $200 Medicare drug cards out by Election Day
CVS to offer free COVID-19 testing to Kent State students, staff
COVID-19 vaccine trial recruiters explain widespread distrust, misinformation among potential enrollees
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
